2021
DOI: 10.1021/acssensors.1c00370
|View full text |Cite
|
Sign up to set email alerts
|

Ophthalmic Sensors and Drug Delivery

Abstract: Advances in multifunctional materials and technologies have allowed contact lenses to serve as wearable devices for continuous monitoring of physiological parameters and delivering drugs for ocular diseases. Since the tear fluids comprise a library of biomarkers, direct measurement of different parameters such as concentration of glucose, urea, proteins, nitrite, and chloride ions, intraocular pressure (IOP), corneal temperature, and pH can be carried out non-invasively using contact lens sensors. Microfluidic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
29
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 44 publications
(29 citation statements)
references
References 243 publications
0
29
0
Order By: Relevance
“…These inbuilt channels or chambers can be employed to load drugs/mRNA/stem cells for promising personalized therapeutic applications. [ 29,54 ] More sophisticated SCL wearable platforms are expected in the future, such as a medical bandage SCL that can simultaneously include biosensing, drug delivery, and electrical stimulation.…”
Section: Outlooks Opportunities and Challengesmentioning
confidence: 99%
See 2 more Smart Citations
“…These inbuilt channels or chambers can be employed to load drugs/mRNA/stem cells for promising personalized therapeutic applications. [ 29,54 ] More sophisticated SCL wearable platforms are expected in the future, such as a medical bandage SCL that can simultaneously include biosensing, drug delivery, and electrical stimulation.…”
Section: Outlooks Opportunities and Challengesmentioning
confidence: 99%
“…To solve these shortcomings, the SCL‐based drug delivery wearable platform has been devised and developed. [ 27–29 ] SCL‐based drug delivery systems are designed to achieve efficient drug encapsulation, accurate drug dose delivery, sustained drug release, adequate drug bioavailability, and better patient compliance. [ 25,29 ] As a very recent example, the first clinical trial investigating LLT‐BMT1, a drug‐eluting SCL product from MediPrint Ophthalmics, has been shown to be safe and well‐tolerable for the treatment of glaucoma.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is particularly relevant when a contact lens is coupled with drug compartments for on-demand delivery. The blend of a multiple-analyte sensor and a feedback-based drug delivery system that act in an automated manner can revolutionize personalized points of care [ 145 ]. Artificial intelligence can be a valuable addition to the study of the therapeutic effects of these smart devices, while machine learning algorithms can provide long-term monitoring of an individual’s health status, thus further improving the course of treatment [ 146 ].…”
Section: Conclusion and Future Prospectsmentioning
confidence: 99%
“…In recent years, the adoption rate of wearable electronics has begun to surge from its prototypical infancy in the early part of the last decade. The demand for such devices is driven by, but not limited to, the increasing desire for continuous health monitoring, 1–4 controlled delivery of nanomedicines, 5–7 advancement of soft robotics, 8–12 and physically immersive virtual/augmented reality products 13–15 . A limitation that these diverse technologies all have in common is the constraints set by current rigid electronics that force their soft environments to conform around them.…”
Section: Introductionmentioning
confidence: 99%